It is very nice to visit Lambda facility and thanks to warm welcome provided by all the teams. I can easily say one of the best CRO I ever visited. People here are wonderful and doing great job

Reputed Client of Israel

Awesome hospitality & fantastic office. All the best!

Reputed Client of Japan

Excellent hospitality and cooperation received throughout the audit. People are knowledgeable and extremely transparent. Looking for long time relation

Reputed Client of Asia

Facility is too good to conduct the BABE studies and adherence to protocol and quality assurance in conducting studies are meeting sponsor expectations and requirements.

Reputed Client of India

Facility is good, people r trained well and know the subject on which they r working. All the best.

Reputed Client of USA

Highly innovative and advanced research centre that possess bright future for the development of the country.

Reputed International Government Body

It is one of the best facility in India for BA/BE

Reputed Regulatory Authority

Lambda is a very professional CRO. All the staff here are experienced and very knowledgeable. I'm grateful for their accommodations and hospitality. The future, if we want to carry out BE study, we will ask Lambda help again.

Reputed Client of Europe

It was a really pleasant meeting with the PV department, and I am looking forward to the next visit.

Reputed Client of Europe

Amazing and best CRO I ever seen

Reputed Client of China



Home / Blog

Overcoming Complexities in Iron Sucrose Analysis: Enhancing Precision & Compliance

23 May 2023

Discover how our team overcame complexities in analyzing iron sucrose, a crucial formulation for treating anemia, by developing and implementing innovative bioanalytical methods using Inductively Coupled Plasma Mass Spectrometry (ICP-MS). By overcoming the complexities, Lambda not only ensured compliance with regulatory requirements but also enhanced analytical sensitivity for precise iron sucrose analysis.

  • Complex Drug Bound Iron Measurement: The regulatory requirement for measuring the PK of the iron product is to measure serum levels of Drug Bound Iron (DI). However, Drug bound iron measurement is complex in the case of iron sucrose. We developed the methods for Total Iron (TI) and Transferrin Bound Iron (TBI) and Drug Bound Iron (DI) shall be calculated using the difference between Total Iron (TI) and Transferrin Bound Iron (TBI).
  • Matrix Selection: Choosing a suitable matrix for the calibration standards and quality control samples posed limitations, requiring careful consideration to ensure accurate and reliable results.
  • Endogenous Iron Levels: Serum from healthy volunteers already has a significant level of endogenous iron. Additionally, the endogenous level is close to the required LLOQ.
  • ICP-MS Methodology: Methods were developed and validated on the ICP-MS instrument. The ICP-MS platform is more selective, sensitive, and compliant with 21 CFR Part 11.
  • Matrix Selection for CC/QCs: Authentic serum was chosen as the matrix for calibration standards and quality control samples, ensuring better resemblance to the study samples.
  • Background Subtraction Approach: To account for endogenous iron levels, a background subtraction approach was utilized to calculate the concentration of the analyte accurately.
Key Outcomes:
  • Method Validation: Robust methods were developed and successfully validated for measuring Total Iron (TI) and Transferrin Bound Iron (TBI) in serum samples, with a lower limit of quantification set at 0.5 μg/mL.
  • Pilot Clinical Study: The validated methods were utilized to analyze serum samples for TI and TBI levels in a pilot clinical study, providing valuable insights into the pharmacokinetics of the iron sucrose product.
  • Efficiency Quality Controls: Additional efficiency quality control samples were prepared using an iron sucrose formulation at various concentration levels to ensure method robustness and mimic the conditions of the study samples.

In addition, the methods complied with regulatory requirements for measuring both Total Iron and Transferrin Bound Iron in serum, ensuring the accuracy and reliability of the analytical data.

To learn more about our experience and capabilities for Bioanalysis and biosimilars, please click here.

Looking for a Globally Proven Research Partner?

Contact Us